Effects of A 100% Perfluorooctylbromide Emulsion on Ischemia/Reperfusion Injury Following Cardioplegia

References

• Protection of the ischemic myocardium: cardioplegia, D. J. Hearse, M. V. Braimbridge, P. Jynge. Raven Press, New York 1981; 5–6
   Google Scholar
• Gettes L. S. Effect of ischemia on cardiac electrophysiology. The Heart and Cardiovascular System, H. A. Fozzard. Raven Press, New York 1986; 1317–1337
   Google Scholar
• Gettes L. S., Cascio M. E., Johnson T., Fleet W F. Local myocardial biochemical and ionic alterations during myocardial ischemia and reperfusion. Drugs 1991; 42(Suppl. I)7–13
   PubMedGoogle Scholar
• Cotgreave I. A., Moldeus P., Orrenius S. Host biochemical defense mechanisms against prooxidants. Ann Rev Pharmacol Toxicol 1988; 28: 189–212
   PubMed Web of Science ®Google Scholar
• Godin D. V., Ko K. M., Garnett M. E. Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinol. Can J Cardiol 1989; 5(7)365–371
   PubMedGoogle Scholar
• Novick R. J., Henry J. S., Michel R. P., Burdon F. D., Salerno T. A. Protection of the hypertrophied pig myocardium: A comparison of crystalloid, blood and Fluosol-DA cardioplegia during prolonged aortic clamping. J Thorac Cardiovasc Surg 1985; 89: 547–566
   PubMed Web of Science ®Google Scholar
• Naito R., Yokoyama K. Perfluorochemical blood substitutes: FC-43 Emulsion, Fluosol-DA, 20% and 35%. Technical Information Series No. 5, The Green Cross Corporation, OsakaJapan 1978; 73–78
   Google Scholar
• Long D. M., Long C., Mattrey R. F., Long R. A., Burgan A. R., Herrick W. C., Shellhammer D. F. An overview of perfluorooctylbromide applications as a synthetic oxygen carrier and imaging agent for x-ray, ultrasound and nuclear magnetic resonance. Biomat Art Cells Art Org 1988; 16(1–3)411–420
   PubMed Web of Science ®Google Scholar
• Riess J. G. Blood substitutes: Where do we stand with the fluorocarbon approach. Current Surgery 1988; 45(5)365–370
   PubMedGoogle Scholar
• Sellevold O. T. M., Jynge P., Arstad K. High performance liquid chromatography. A rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol 1986; 18: 517–527
   PubMed Web of Science ®Google Scholar
• Anderson M. E. Determination of glutathione and glutathione disulfide in biological samples. Methods In Enzymol 1985; 113: 548–555
   PubMed Web of Science ®Google Scholar
• Flohe L., Gunzler W. A. Assays of glutathione peroxidase. Methods In Enzymol 1984; 105: 114–121
   PubMed Web of Science ®Google Scholar
• Cohen G., Dembiec D., Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970; 34: 30–38
   PubMed Web of Science ®Google Scholar
• Maestro R. F. O., McDonald W. Oxidative enzymes in tissue homogenates. Handbook of Methods for Oxygen Radical Research, R. A. Greenwald. CRC Press, Boca Raton, FL 1985; 291–296
   Google Scholar
• Principles and Procedures of Statistics, R. G. D. Steel, J. H. Torrie. McGraw-Hill Book Company, Inc., New York 1960
   Google Scholar
• Shlafer M., Kane P. F., Kirsch M. M. Superoxide plus catalase enhances the efficiency of hypothermic cardioplegia to protect the globally ischemic and reperfused heart. J Thorac Cardiovasc Surg 1982; 82: 830–839
   Google Scholar
• Ledingham S. J. M., Katayama O., Lachno D. R., Yacoub M. Prolonged cardiac preservation: Evaluation of the University of Wisconsin preservation solution by comparison with the St. Thomas' Hospital cardioplegic solution in the rat. Circulation 1990; 82(Suppl. IV)351–358
   Google Scholar
• Ferrari R., Ceconi C., Currello S., Guarnieri C., Caldarera C. M., Albertini A., Visioli O. Oxygen-mediated myocardial damage during ischemia and reperfusion: Role of the cellular defenses against oxygen toxicity. J Mol Cell Cardiol 1985; 17: 937–945
   PubMed Web of Science ®Google Scholar
• Guarnieri C., Flamigni F., Caldarera M. C. Role of oxygen in cellular damage induced by re-oxygenation of the hypoxic heart. J Mol Cell Cardiol 1980; 12: 797–808
   PubMed Web of Science ®Google Scholar
• Dikshit M., Van Osten M. H., de Graff S., Srimal R. C. Free radical scavenger mechanims in experimentally induced ischemia in the rabbit heart and protective effect of verapamil. Arch Int Pharmacodyn Ther 1992; 318: 55–65
   PubMedGoogle Scholar
• Coudray C., Pucheu S., Boucher F., de Leiris J., Favier A. Ischemia and reperfusion injury in isolated rat heart: effect of reperfusion duration on xanthine oxidase, lipid peroxidation, and enzyme antioxidant systems in myocardium. Basic Res Cardiol 1992; 87: 478–88
   PubMed Web of Science ®Google Scholar
• Rao P. S., Cohen M. V., Mueller H. S. Production of radicals and lipid peroxides in early experimental myocardial ischemia. J Mol Cell Cardiol 1983; 15: 713–716
   PubMed Web of Science ®Google Scholar
• Ceconi C., Curello S., Cargnoni A., Ferrari R., Albertini A., Visioli O. The role of glutathione status in the protection against ischemic and reperfusion damage: Effects of N-acetyl cysteine. J Mol Cell Cardiol 1988; 12: 109–133
   Google Scholar
• Jennings R. B., Hawkins H. K., Lowe J. E., Hill M. L., Klotman S., Reimer K. A. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol 1978; 92: 187–214
   PubMed Web of Science ®Google Scholar
• Glogar D. H., Joner R. K.A., Muller J., Deboer L. W. V., Braunwald E. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science 1981; 211: 1439–1441
   PubMed Web of Science ®Google Scholar
• Bando K., Teramoto S., Tago M., Seno S., Murakami T., Nawa S., Senoo Y. Oxygenated perfluorcarbon, recombinant human superoxide dismutase and catalase ameliorate free radical induced myocardial injury during heart preservation and transplantation. J Thorac Cardiovasc Surg 1988; 96: 930–938
   PubMed Web of Science ®Google Scholar
• Flaherty J. T., Jaffin J. H., Magovern G. J., Kanter K. K., Gardner T. J., Miceli M. V., Jacobus W. E. Maintenance of aerobic metabolism during global ischemia with perfluorocarbon cardioplegia improves myocardial preservation. Circulation 1984; 69: 585–592
   PubMed Web of Science ®Google Scholar
• Rude R. E., Golgar D., Khuri S. F. Effects of intravenous fluorocarbons with and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tension. Am Heart J 1982; 103: 986–995
   PubMedGoogle Scholar
• Fischer J. J., Rockwell S., Martin D. F. Perflurorchemicals and hyperbaric oxygen in radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12: 95–102
   PubMed Web of Science ®Google Scholar
• Rahamathulla P. M., Watanabe K., Ashraf M., Millar R. W. Prevention of lactate production and myocyte injury in isolated rat hearts perfused with perfluorocrbon emulsion. Exp Pathol 1985; 28(3)157–165
   PubMedGoogle Scholar
• Menash P., Grousset C., Mouas C., Moore R. E., Piwnica A. Enhancement of cardioplegic protection with a lecithin-based perfluoroadamantane emulsion. Biomat Art Cells Art Org 1988; 16(l-3)607–616
   PubMedGoogle Scholar
• Irem S. O., Eyer C. L., Smith J. R., Anderson A. C. Protective effects of selected sulfhydryl containing compounds against global ischemia in isolated perfused rat hearts. Proc West Pharmacol Soc 1991; 34: 161–165
   PubMedGoogle Scholar
• Grover G. J., Sleph P. G. Dissociation of cardiodepression from cardioprotection with calcium antagonists: Diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine. J Cardiovasc Pharmacol 1989; 14: 331–340
   PubMedGoogle Scholar
• Sargent C. A., Sleph P. G., Dzwonczyk S., Smith M. A., Grover G. J. Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts. J Cardiovasc Pharmacol 1992; 20: 251–259
   PubMedGoogle Scholar